Literature DB >> 29949090

Onset of symptoms, diagnostic confirmation, and occurrence of multiple infective foci in patients with Staphylococcus aureus bloodstream infection: a look into the order of events and potential clinical implications.

Jesper Smit1,2,3, Siegbert R Rieg4, Andreas F Wendel5, Winfried V Kern4, Harald Seifert6,7, Henrik C Schønheyder1,8, Achim J Kaasch9.   

Abstract

PURPOSE: Data on the systemic dissemination in Staphylococcus aureus bloodstream infection (SAB) remain sparse. We investigated the timing and the sequence of clinical symptoms, diagnostic confirmation, and occurrence of multiple infective foci in relation to three major infective foci.
METHODS: From 2006 to 2011, all adult patients with first-time SAB in Cologne and Freiburg, Germany were followed prospectively. The study was restricted to patients with short-term central venous catheter (CVC)-related SAB, vertebral osteomyelitis (VO), and infective endocarditis (IE). The collection date of the first positive blood culture was used as reference point for determining time to onset of clinical symptoms, microbiological findings, imaging results compatible with focal infection, and occurrence of additional infective foci.
RESULTS: We included 266 patients with first-time SAB. Among patients with CVC-related SAB, clinical onset, collection of the first positive blood culture, and microbiological confirmation almost coincided. In contrast, among patients with VO or IE, the onset of clinical symptoms most often preceded the collection of the first positive blood culture, and imaging and microbiological confirmation were most frequently obtained subsequent to the SAB diagnosis. CVC-related SAB was infrequently associated with further foci (n = 15/15.5%). Conversely, more than one infective focus was observed in 44 (56.4%) patient with VO and 68 (64.8%) patients with IE.
CONCLUSIONS: The sequence of clinical symptoms, diagnostic confirmation, and occurrence of multiple infective foci varied considerably with different infective foci in SAB. Based on these results, we propose a pragmatic and evidence-based terminology for the clinical course of SAB and suggest the terms "portal of entry", "infective focus", "multiple infective foci", and "dominant infective focus".

Entities:  

Keywords:  Clinical course; Infective focus; Staphylococcus aureus bloodstream infection; Terminology

Mesh:

Year:  2018        PMID: 29949090     DOI: 10.1007/s15010-018-1165-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  24 in total

1.  Metastatic complications of Staphylococcus aureus septicemia. To seek is to find.

Authors:  H Ringberg; A Thorén; B Lilja
Journal:  Infection       Date:  2000 May-Jun       Impact factor: 3.553

Review 2.  Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?

Authors:  Raphael Saginur; Kathryn N Suh
Journal:  Int J Antimicrob Agents       Date:  2008-08-30       Impact factor: 5.283

Review 3.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

4.  Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.

Authors:  M L H Cuijpers; F J Vos; C P Bleeker-Rovers; P F M Krabbe; P Pickkers; A P J van Dijk; G J A Wanten; P D Sturm; W J G Oyen; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

5.  Clinical significance of Staphylococcus aureus bacteriuria in a nationwide study of adults with S. aureus bacteraemia.

Authors:  Hilmir Asgeirsson; Mar Kristjansson; Karl G Kristinsson; Olafur Gudlaugsson
Journal:  J Infect       Date:  2011-10-25       Impact factor: 6.072

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia.

Authors:  Achim J Kaasch; Vance G Fowler; Siegbert Rieg; Gabriele Peyerl-Hoffmann; Hanna Birkholz; Martin Hellmich; Winfried V Kern; Harald Seifert
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

8.  Staphylococcus aureus bacteremia. Current clinical patterns.

Authors:  C M Nolan; H N Beaty
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

9.  Patients at risk of complications of Staphylococcus aureus bloodstream infection.

Authors:  Ana del Rio; Carlos Cervera; Asunción Moreno; Phillipe Moreillon; José M Miró
Journal:  Clin Infect Dis       Date:  2009-05-15       Impact factor: 9.079

10.  Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies.

Authors:  Achim J Kaasch; Gavin Barlow; Jonathan D Edgeworth; Vance G Fowler; Martin Hellmich; Susan Hopkins; Winfried V Kern; Martin J Llewelyn; Siegbert Rieg; Jesús Rodriguez-Baño; Matthew Scarborough; Harald Seifert; Alex Soriano; Robert Tilley; M Estée Tőrők; Verena Weiß; A Peter R Wilson; Guy E Thwaites
Journal:  J Infect       Date:  2013-11-16       Impact factor: 6.072

View more
  2 in total

1.  C-reactive protein predicts complications in community-associated S. aureus bacteraemia: a cohort study.

Authors:  Carly L Botheras; Steven J Bowe; Raquel Cowan; Eugene Athan
Journal:  BMC Infect Dis       Date:  2021-04-01       Impact factor: 3.090

2.  Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.

Authors:  Kathrin Rothe; Nina Wantia; Christoph D Spinner; Jochen Schneider; Tobias Lahmer; Birgit Waschulzik; Roland M Schmid; Dirk H Busch; Juri Katchanov
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.